Article
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
23 Nov 2016
Abstract excerpt
Abstract Preclinical studies using bone marrow derived cells to treat traumatic brain injury have demonstrated efficacy in terms of blood–brain barrier preservation, neurogenesis, and functional outcomes. Phase 1 clinical trials using bone marrow mononuclear cells infused intravenously in children with severe traumatic brain injury demonstrated safety and potentially a central nervous system structural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
